HealthSource review

HealthSource Online sells a broad telehealth catalog with separate weight-loss, wellness, sexual-health and beauty products. Its GLP-1 offer includes semaglutide injection, tirzepatide injection and tirzepatide oral drops. The important price detail is printed directly beside the products: injections are billed every four weeks, which is a different annual expense from twelve monthly payments.

The program may appeal to a woman who wants several delivery options and ongoing clinician messaging. The public material is less complete about a women's specialty care plan and the exact dose-specific purchase. This review evaluates the published service and policies.

What does the four-week charge include?

The storefront advertises semaglutide from $199 every four weeks and tirzepatide injection from $299 every four weeks. An uninterrupted fifty-two-week schedule contains thirteen four-week periods, so those amounts correspond to $2,587 and $3,887 over that schedule, before any different term, add-on or price change. A calendar-month comparison can otherwise understate the annual cost.

The tirzepatide product page offers full-dose and several starter-supply variants, including four weeks, six weeks and eight weeks. The presence of these choices does not establish that every personalized order has the same supply or that a storefront starting price applies to every variant. Obtain the complete price for the selected supply, dose and refill schedule before treating it as a final quote.

The reviewed injection page includes the online visit, ongoing support and unlimited messaging with the doctor about side effects or dosage. It also says recurring payments are automatically refunded if the monthly reassessment is not completed. That is a specific billing provision, not a reason to skip clinical follow-up or assume that canceling after pharmacy processing is refundable.

The oral tirzepatide option has its own product listing and should be priced separately. Drops and injections are different formulations. Choosing an oral product to avoid needles does not establish equal absorption, outcomes or approval status. Ask what the clinician is recommending and why it is appropriate for you; our compounded versus brand-name guide explains those product distinctions.

Who is responsible for the care?

HealthSource's terms describe a facilitator connecting users with independent licensed providers and pharmacies. The company says it does not practice medicine or pharmacy and does not control the professional judgment of those providers. An account on the platform is therefore not the same thing as a prescription or a clinical relationship with the storefront itself.

The advertised process moves from a health intake to practitioner approval and pharmacy fulfillment. The site describes a U.S.-based 503A partner pharmacy and says medication and supplies arrive with tracking after approval. That description does not identify the pharmacy assigned to every individual order. Request its name, the actual product ingredients, quantity and concentration, especially if you are continuing a prescription started elsewhere.

The product pages advertise doctor messaging and continuing support, but do not publish a fixed response deadline for every medical question. Establish how to reach the prescriber, whether any live follow-up is included and where to seek help if the portal is not an appropriate channel. The contact page's customer-service details do not by themselves establish clinical availability around the clock.

The website uses strong outcome language around compounded tirzepatide. Those marketing projections are not a guaranteed result and should not replace an individual assessment. A suitable clinician should be able to explain the treatment goal, follow-up schedule and options if you cannot tolerate the prescribed preparation, rather than promise a particular percentage loss.

Does the wider catalog mean women's hormone care?

The catalog includes sexual-health products such as Addyi, along with wellness treatments. That breadth is relevant to understanding what the store offers, but it does not establish comprehensive menopause hormone therapy or specialist PCOS care. A product classified under women's health is not a complete program for estrogen-related symptoms, irregular bleeding or fertility planning.

For a woman whose weight concern overlaps with PCOS, ask whether the clinician can coordinate with her gynecologist or endocrinologist. The reviewed weight-loss material does not set out a dedicated PCOS monitoring pathway. Our GLP-1 and PCOS guide can help identify the separate clinical questions before choosing a general prescription program.

Similarly, hormone testimonials do not establish which women's HRT prescriptions are currently available or included. If you already use hormone therapy, disclose it during assessment and ask who remains responsible for changes to that treatment. An expanded storefront is useful only if the clinical scope matches what you need.

Renewal, refunds and delivery problems

Subscriptions automatically renew unless canceled 48 hours before renewal, according to the terms. The refund policy permits cancellation through account settings, but says an already processed charge for the current cycle is non-refundable and future cancellation takes effect at the end of that cycle. Act before the renewal and pharmacy submission rather than wait for the shipping notification.

The prescription policy is particularly restrictive: orders completed by practitioners and sent to the pharmacy are described as non-refundable. Once processed, prescription products cannot be returned. The broader thirty-day return language on the same page applies to eligible unopened non-prescription items, not a general right to send back prescription medication.

Order issues should be reported within twenty-four hours of receiving medication. The policy separately discusses damaged, defective or incorrect products and possible replacement. Save the packaging and contact support promptly if the shipment appears compromised. Do not interpret a general shipping estimate as permission to use medication with uncertain storage conditions.

HealthSource is most useful to compare when you want a four-week compounded plan with clinician messaging and potentially an oral route. The trade-offs are early refund cutoffs, variant-specific supply questions and limited evidence of a specialist women's program. Before starting, use the provider-selection guide to obtain a written total and a clear clinical follow-up plan.